Correlation Engine 2.0
Clear Search sequence regions

  • adult (1)
  • corticoid (1)
  • female (1)
  • glucocorticoids (2)
  • heart block (9)
  • humans (1)
  • patient (5)
  • research (1)
  • sinus node (1)
  • Sizes of these terms reflect their relevance to your search.

    The present article aims at describing a rare case of an RP patient who evolved with heart block and was successfully treated with corticoid pulse therapy, without the need for pacemaker insertion. A systematic research on relapsing polychondritis (RP) and heart block (HB) published in PubMed/MEDLINE, Web of Sciences, LILACS, and Scielo from 1966 to August 2020 was performed. It was found 10 studies on RP associated with HB, and we added a case. Most were male (7/10) with ages 30 to 66 years old. RP disease duration was 1 week-6 years. In most cases (7/10), the RP was active when the HB occurred. A complete HB was observed in 4/7, followed by type II degree block in 3/7, and one patient had a sinus node dysfunction. Most patients received glucocorticoids. A pacemaker was inserted in 4/9 cases. Good outcome was observed in 3/9 patients and mortality in 2/10. We report the first case of an RP patient who had a heart block and was successfully treated with methylprednisolone pulse therapy. The authors suggest that in these RP cases, an attempt with a glucocorticoid pulse therapy may be offered to treat the heart block and prevent the insertion of a pacemaker.


    J F de Carvalho, L C Behrmann Martins, A F Cardoso, Y Shoenfeld. Relapsing polychondritis associated with heart block. European review for medical and pharmacological sciences. 2021 Feb;25(4):2050-2055

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33660817

    View Full Text